tiprankstipranks
Mochida Pharmaceutical Co., Ltd. (DE:MFY)
FRANKFURT:MFY
Germany Market

Mochida Pharmaceutical Co., Ltd. (MFY) Financial Statements

Compare
0 Followers

Mochida Pharmaceutical Co., Ltd. Financial Overview

Mochida Pharmaceutical Co., Ltd.'s market cap is currently €686.77M. The company's EPS TTM is €0.98; its P/E ratio is 19.28; and it has a dividend yield of 2.60%. Mochida Pharmaceutical Co., Ltd. is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue¥ 102.89B¥ 103.26B¥ 110.18B¥ 103.00B¥ 101.80B
Gross Profit¥ 52.07B¥ 55.12B¥ 59.55B¥ 54.79B¥ 51.92B
Operating Income¥ 5.80B¥ 8.51B¥ 14.39B¥ 12.00B¥ 8.81B
EBITDA¥ 8.97B¥ 11.71B¥ 17.28B¥ 14.75B¥ 11.54B
Net Income¥ 4.55B¥ 6.65B¥ 10.57B¥ 8.59B¥ 4.60B
Balance Sheet
Cash & Short-Term Investments¥ 46.79B¥ 60.51B¥ 61.91B¥ 63.49B¥ 61.29B
Total Assets¥ 158.80B¥ 158.83B¥ 163.14B¥ 161.79B¥ 157.49B
Total Debt¥ 0.00¥ 190.00M¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -33.29B¥ -46.82B¥ -48.41B¥ -54.49B¥ -53.29B
Total Liabilities¥ 30.84B¥ 32.06B¥ 34.50B¥ 34.82B¥ 36.83B
Stockholders' Equity¥ 127.97B¥ 126.77B¥ 128.64B¥ 126.97B¥ 120.66B
Cash Flow
Free Cash Flow¥ -9.78B¥ 5.13B¥ 4.36B¥ 7.11B¥ 7.39B
Operating Cash Flow¥ -7.48B¥ 7.30B¥ 7.46B¥ 9.20B¥ 9.35B
Investing Cash Flow¥ 74.00M¥ -2.95B¥ -2.01B¥ -880.00M¥ -1.76B
Financing Cash Flow¥ -6.39B¥ -6.88B¥ -5.96B¥ -5.11B¥ -5.33B
Currency in JPY

Mochida Pharmaceutical Co., Ltd. Earnings and Revenue History

Mochida Pharmaceutical Co., Ltd. Debt to Assets

Mochida Pharmaceutical Co., Ltd. Cash Flow

Mochida Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis